These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15090034

  • 1. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness.
    Ransome MI, Goldshmit Y, Bartlett PF, Waters MJ, Turnley AM.
    Eur J Neurosci; 2004 Apr; 19(8):2069-79. PubMed ID: 15090034
    [Abstract] [Full Text] [Related]

  • 2. Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2.
    Ransome MI, Turnley AM.
    Neuroscience; 2005 Apr; 132(3):673-87. PubMed ID: 15837129
    [Abstract] [Full Text] [Related]

  • 3. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
    Turnley AM, Faux CH, Rietze RL, Coonan JR, Bartlett PF.
    Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone and SOCS2 regulation of neuronal differentiation: possible role in mental function.
    Turnley AM.
    Pediatr Endocrinol Rev; 2005 Mar; 2(3):366-71. PubMed ID: 16429112
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of SOCS2 on neuronal differentiation and morphology.
    Scott HJ, Stebbing MJ, Walters CE, McLenachan S, Ransome MI, Nichols NR, Turnley AM.
    Brain Res; 2006 Jan 05; 1067(1):138-45. PubMed ID: 16360125
    [Abstract] [Full Text] [Related]

  • 6. Suppressor of cytokine signalling-2 and epidermal growth factor regulate neurite outgrowth of cortical neurons.
    Goldshmit Y, Greenhalgh CJ, Turnley AM.
    Eur J Neurosci; 2004 Nov 05; 20(9):2260-6. PubMed ID: 15525267
    [Abstract] [Full Text] [Related]

  • 7. Role of SOCS2 in growth hormone actions.
    Turnley AM.
    Trends Endocrinol Metab; 2005 Mar 05; 16(2):53-8. PubMed ID: 15734145
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone promotes proliferation of adult neurosphere cultures.
    McLenachan S, Lum MG, Waters MJ, Turnley AM.
    Growth Horm IGF Res; 2009 Jun 05; 19(3):212-8. PubMed ID: 18976947
    [Abstract] [Full Text] [Related]

  • 9. Knock your SOCS off!
    Leroith D, Nissley P.
    J Clin Invest; 2005 Feb 05; 115(2):233-6. PubMed ID: 15690080
    [Abstract] [Full Text] [Related]

  • 10. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ, Simmons JG, Ramocki NM, Scull BP, McNaughton KK, Fuller CR, Lund PK.
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep 05; 291(3):G472-81. PubMed ID: 16574995
    [Abstract] [Full Text] [Related]

  • 11. Lack of Socs2 expression causes the high-growth phenotype in mice.
    Horvat S, Medrano JF.
    Genomics; 2001 Mar 01; 72(2):209-12. PubMed ID: 11401434
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone signaling and hippocampal neurogenesis: insights from genetic models.
    Ransome MI, Turnley AM.
    Hippocampus; 2008 Mar 01; 18(10):1034-50. PubMed ID: 18566962
    [Abstract] [Full Text] [Related]

  • 13. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E, Greenhalgh CJ, Tollet-Egnell P, Hilton DJ, Alexander WS, Norstedt G, Flores-Morales A.
    Mol Endocrinol; 2005 Mar 01; 19(3):781-93. PubMed ID: 15563548
    [Abstract] [Full Text] [Related]

  • 14. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.
    Kishi N, Macklis JD.
    Mol Cell Neurosci; 2004 Nov 01; 27(3):306-21. PubMed ID: 15519245
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT, Singal PK, Al-Banaw A.
    Anticancer Res; 2007 Nov 01; 27(6B):4201-18. PubMed ID: 18225592
    [Abstract] [Full Text] [Related]

  • 16. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ.
    J Clin Invest; 2005 Feb 01; 115(2):397-406. PubMed ID: 15690087
    [Abstract] [Full Text] [Related]

  • 17. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA, Cosme-Blanco W, Difedele LM, Bonkowski EL, Menon RK, Denson LA.
    Am J Physiol Gastrointest Liver Physiol; 2005 May 01; 288(5):G986-93. PubMed ID: 15604202
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic STAT proteins: regulation of somatostatin neurones by growth hormone via STAT5b.
    Bennett E, McGuinness L, Gevers EF, Thomas GB, Robinson IC, Davey HW, Luckman SM.
    J Neuroendocrinol; 2005 Mar 01; 17(3):186-94. PubMed ID: 15796771
    [Abstract] [Full Text] [Related]

  • 19. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
    Fruchtman S, Simmons JG, Michaylira CZ, Miller ME, Greenhalgh CJ, Ney DM, Lund PK.
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug 01; 289(2):G342-50. PubMed ID: 15831713
    [Abstract] [Full Text] [Related]

  • 20. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5.
    Sims NA, Clément-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA.
    J Clin Invest; 2000 Nov 01; 106(9):1095-103. PubMed ID: 11067862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.